As part of the MedStar Health Cancer Network, the clinical trials programs at MedStar Good Samaritan and MedStar Union Memorial Hospitals conduct research in many areas of cancer treatment and serve an essential role in the fight against cancer.
To learn more about the specific trials currently offered at MedStar Good Samaritan Hospital, see the following sections:
For more information about our clinical trials, please call 410-261-8151. Click here to find out more about the clinical trials offered at MedStar Union Memorial Hospital.
Frequently Asked Questions about Clinical Trials
What is a clinical trial and why should you participate?
A clinical trial is a research study. People who participate receive either treatments not yet available to the general public, or available treatments used in new ways or in new combinations.
Clinical trials can offer the most up-to-date treatment for your cancer, and can represent a significant improvement in your care, especially if your first-line therapy has not been successful.
Participation means that you will receive the additional support of a research nurse. Your research nurse will be your advocate and will see to it that your treatment regimen follows strict clinical trial instructions. At the end of your treatment, your research nurse will continue to call you or your doctor to follow up on your condition.
What clinical trials are available?
The many cancer trials open for patient enrollment focus on the prevention, treatment, or palliation of different types of cancer. Most come with a quality of life component.
What safeguards are in place before a clinical trial is offered?
Before a clinical trial is made available, it is reviewed by the MedStar Oncology Institutional Review Board. The IRB is a group of doctors, nurses, researchers, and community representatives who decide whether the clinical trial is safe and effective and whether it is based on the best interests of the people who will participate in it. Guidelines regulating these decisions are set by the U.S. Department of Health and Human Services.
Patients must also meet the specific criteria of the trial (i.e., stage of disease) and they must sign an informed consent that states they have been advised of all the medical aspects of the clinical trial. The doctor and the research nurse individually educate the patient about the regimen of treatment to be received.
Who sponsors clinical trials?
Our cancer trials are sponsored by multi-institutional research groups supported by the National Cancer Institute (NCI), pharmaceutical companies, and independent investigators.
We are part of the MedStar Oncology Network which is a collaborative oncology research effort involving all MedStar hospitals including Georgetown (Lombardi Cancer Institute), Washington Hospital Center (Washington Cancer Institute), and MedStar community hospitals.
Can I discontinue treatment if I change my mind?
Yes. You are free to discontinue treatment at any time. This will not affect your relationship with your doctor. Your doctor and cancer program staff will provide other available care. In fact, if your doctor believes that the treatment you receive in the clinical trial is not helping, or that its side effects are too harmful, he or she will take you out of the study.
How will I be billed for my treatment?
Billing is the same for clinical trial participants and non-participants. Treatments are charged to your insurance company. Other sources of funding may cover additional costs of the clinical trial.
MedStar Good Samaritan Hospital
(MedStar Franklin Square Cancer Center at Loch Raven Campus)
5601 Loch Raven Blvd.
Russell Morgan Building, Suite 103
Baltimore, MD 21239
MedStar Union Memorial Hospital
3333 North Calvert Street
Johnston Professional Building, Suite 107
Baltimore, MD 21218
Clinical Research Coordinators
Barb Rector, RN